A substituted pyrrole pyrimidine compound and a composition containing the compound are provided and their applications. Specifically, the pyrropyrimidine compound, as shown in I, or its crystalline form, pharmaceutically acceptable salts, prodrugs, stereoisomers, hydrates, or solvent compounds. The compound can be used as a cyclin dependent kinase (CDK) inhibitor, and can be applied to the preparation of drugs for the treatment of CDK related diseases, such as breast cancer, etc.
【技术实现步骤摘要】
【国外来华专利技术】PCT国内申请,说明书已公开。
【技术保护点】
PCT国内申请,权利要求书已公开。
【技术特征摘要】
【国外来华专利技术】2016.06....
【专利技术属性】
技术研发人员:王义汉,邢青峰,
申请(专利权)人:深圳市塔吉瑞生物医药有限公司,
类型:发明
国别省市:广东,44
还没有人留言评论。发表了对其他浏览者有用的留言会获得科技券。